Skip to content
GHRH analogs and growth-hormone-secretagogue research peptides studied for the GH/IGF-1 axis.

Check who was treated

What can these study reviews help you judge?

These reviews help you check who received a drug and what changed. The people explaining the papers provide reading help, without offering medical care.

What these reviews help you bring to a medical visit

The four drugs have unequal evidence for useful treatment benefits. These reviews help you check a claim against the patients' results.

Clinical Peptide Literature Review is people explaining published medical papers. They provide reading help, without clinic visits or medical treatment.

Tesamorelin, sermorelin, CJC-1295 and ipamorelin can raise growth hormone. Their studies range from an approved use to early blood tests.

Your interest may concern deep belly fat, sleep or aging. Researchers need to measure the proposed change in patients sharing that problem.

The comparison places each drug beside the people and findings. The separate drug pages explain those findings and their limits.

The FAQ discusses benefits and possible harms that readers ask about. Bracketed numbers lead to the supporting papers in the reference list.

The findings come from published trials, reviews and expert opinions. Reviews examine completed studies; opinions argue what might help.

Improved daily health requires more proof than raised blood hormones. An animal benefit also leaves the same benefit in humans unproved.

Bring your doctor the claim and the finding behind it. Ask whether the patients studied had a problem like yours.

What a trial adds beyond an opinion or personal account

A rat experiment doesn't establish benefits for an older adult. First check who received the treatment and what was measured.

A trial follows people receiving treatment under planned conditions. For comparison, some patients receive placebo, which contains no active drug.

A review examines studies that researchers have already completed. An expert opinion offers reasons for treatment or further study.

Neither paper tests a new group receiving the drug. Your benefit question still needs findings from people with your problem.

People describe their experiences after trying peptides for research outside trials. These personal reports haven't been checked by controlled comparisons with placebo.

Calling use research doesn't prove that anyone supervised treatment. The cause of changes and the frequency of problems remain uncertain.

A bracketed number directs you to the supporting paper. The drug page describes the patients and the treatment period.

Check the measured change against the change being claimed. Higher hormones don't prove better sleep or recovery after exercise.

The gland's blood response shows that hormone release changed. To prove a daily benefit, researchers must measure how patients' health changed.

What the findings leave for your doctor to assess

Tesamorelin's approval concerns a particular deep belly-fat problem in HIV patients [2]. Other causes of a growing waist need separate treatment evidence.

Children gained height with sermorelin; healthier adult aging remained unproved [10][12]. Your age group needs testing for the benefit being proposed.

CJC-1295 blood changes didn't establish better muscle gain or exercise recovery [15][16]. Ipamorelin didn't prove quicker bowel recovery in people [19][20].

Your doctor needs your symptoms, medicines and health history together. The people explaining these papers can't provide that personal care.

They don't sell drugs, operate a pharmacy or arrange referrals. They can't test your bottle or choose treatment for you.

A popular drug may still lack proof of benefits or harms. An explanation of hormone action doesn't fill that gap.

At your visit, name the change you hope to gain. Ask what happened in patients with a problem like yours.

What a paper summary leaves open about your choice

A paper summary alone can't decide your treatment choice. Your symptoms, medicines and other illnesses need your doctor's assessment.

A printed bottle name doesn't prove the contents match. Bottle purity and contents require their own tests.

New studies may find previously unknown benefits or harms. They may also find no useful benefit from a hormone rise.

Check who received the drug and what the researchers measured. The study's question may not address your own medical problem.

Animal findings leave the same effect in humans unproved. Short treatment leaves years of possible harm uncertain.

Name your unanswered question when discussing the proposed treatment. Knowing how a drug acts doesn't establish how patients will feel.